The Patent Finder

Ceftolozane-Tazobactam Pharmaceutical Compositions

Merck Sharp and Dohme LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application 61/793,007, filed Mar 15, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,044,485Ceftolozane Antibiotic Compositions
In force
 · Low confidence
Merck Sharp & Dohme LLCIn force
Low confidence
US 9,320,740Ceftolozane-Tazobactam Pharmaceutical Compositions
In force
 · High confidence
Merck Sharp & Dohme LLCIn force
High confidence
US 9,872,906Ceftolozane Antibiotic Compositions
In force
 · High confidence
Merck Sharp & Dohme LLCIn force
High confidence
US 9,925,196Ceftolozane-Tazobactam Pharmaceutical Compositions
In force
 · High confidence
Merck Sharp & Dohme LLCIn force
High confidence
US 10,420,841Ceftolozane Antibiotic Compositions
In force
 · High confidence
Merck Sharp & Dohme LLCIn force
High confidence
US 11,278,622Ceftolozane Antibiotic Compositions
In force
 · Medium confidence
Merck Sharp & Dohme LLCIn force
Medium confidence
Application 14/251,381Ceftolozane Antibiotic Compositions
Abandoned
Abandoned Jul 7, 2016
Merck Sharp & Dohme Corp.AbandonedAbandoned Jul 7, 2016
Application 15/086,479Ceftolozane Antibiotic Compositions
Abandoned
Abandoned Apr 28, 2017
Merck Sharp & Dohme Corp.AbandonedAbandoned Apr 28, 2017
Application 15/895,279Ceftolozane-Tazobactam Pharmaceutical Compositions
Abandoned
Abandoned Oct 29, 2019
Merck Sharp & Dohme Corp.AbandonedAbandoned Oct 29, 2019
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Merck Sharp and Dohme LLC.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited